Page 16 - 南京医科大学自然版
P. 16

第45卷第2期
               ·156 ·                            南 京    医 科 大 学 学         报                        2025年2月


                   high efficient way of PCR amplification of random DNA li⁃  [25]CIVIT L,TAGHDISI S M,JONCZYK A,et al. Systematic
                   braries in aptamer selection[J]. PLoS One,2011,6(9):  evaluation of cell ⁃ SELEX enriched aptamers binding to

                   e24910                                            breast cancer cells[J]. Biochimie,2018,145:53-62
             [20]GRAHAM J C,ZARBL H. Use of cell⁃SELEX to generate  [26]LU M,ZHOU L,ZHENG X H,et al. A novel molecular
                   DNA aptamers as molecular probes of HPV ⁃ associated  marker of breast cancer stem cells identified by cell ⁃
                   cervical cancer cells[J]. PLoS One,2012,7(4):e36103  SELEX method[J]. Cancer Biomark,2015,15(2):163-170
             [21]王芹芹,胡      慧,崔军威,等. 指数富集配基系统进化技                [27]RAHIMIZADEH K,ALSHAMAILEH H,FRATINI M,et
                   术筛选三阴乳腺癌适配子中聚合酶链反应扩增条件的                           al. Development of cell⁃specific aptamers:recent advances
                   优化及单链 DNA 的制备[J]. 中华实验外科杂志,                       and insight into the selection procedures[J]. Molecules,
                   2014,31(12):2732⁃2734                             2017,22(12):2070
                   WANG Q Q,HU H,CUI J W,et al. Selecting aptamers of  [28]KAUR H. Recent developments in cell⁃SELEX technology
                   triple negative breast cancer by systematic evaluation of li⁃  for aptamer selection[J]. Biochim Biophys Acta Gen
                   gands by exponential enrichment:addressing the poly⁃  Subj,2018,1862(10):2323-2329
                   merase chain reaction and single⁃stranded DNA genera⁃  [29]NEVE R M,CHIN K,FRIDLYAND J,et al. A collection
                   tion issues[J]. Chinese Journal of Experimental Surgery,  of breast cancer cell lines for the study of functionally dis⁃

                   2014,31(12):2732-2734                             tinct cancer subtypes[J]. Cancer Cell,2006,10(6):515-
             [22]MOOSAVIAN S A,JAAFARI M R,TAGHDISI S M,et al.       527
                   Development of RNA aptamers as molecular probes for  [30]PARK B J,WHICHARD Z L,COREY S J. Dasatinib syn⁃
                   HER2(+)breast cancer study using cell⁃SELEX[J]. Iran  ergizes with both cytotoxic and signal transduction inhibi⁃
                   J Basic Med Sci,2015,18(6):576-586                tors in heterogeneous breast cancer cell lines:lessons for
             [23]LIU M,YANG T,CHEN Z S,et al. Differentiating breast  design of combination targeted therapy[J]. Cancer Lett,
                   cancer molecular subtypes using a DNA aptamer selected  2012,320(1):104-110
                   against MCF ⁃ 7 cells[J]. Biomater Sci,2018,6(12):  [31]CHADALAVADA D M,BEVILACQUA P C. Analyzing
                   3152-3159                                         RNA and DNA folding using temperature gradient gel
             [24]LI W M,ZHOU L L,ZHENG M,et al. Selection of meta⁃   electrophoresis(TGGE)with application to in vitro selec⁃
                   static breast cancer cell⁃specific aptamers for the capture  tions[J]. Methods Enzymol,2009,468:389-408
                   of CTCs with a metastatic phenotype by cell⁃SELEX[J].                  [收稿日期] 2024-08-01
                   Mol Ther Nucleic Acids,2018,12:707-717                                     (本文编辑:陈汐敏)
   11   12   13   14   15   16   17   18   19   20   21